Cited by 239

Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells

Kaplan, Daniel H., Li, Ming O., Jenison, Matthew C., Shlomchik, Warren D., Flavell, Richard A., Shlomchik, Mark J.·2007·The Journal of Experimental Medicine

Abstract

Langerhans cells (LCs) are bone marrow (BM)–derived epidermal dendritic cells (DCs) that develop from precursors found in the dermis. Epidermal LCs are absent in transforming growth factor (TGF) β1-deficient mice. It is not clear whether TGFβ1 acts directly on LC precursors to promote maturation or whether it acts on accessory cells, which in turn affect LC precursors. In addition, the physiologic source of TGFβ1 is uncertain because BM chimera experiments showed that neither hematopoietic nor nonhematopoietic-derived TGFβ1 is required for LC development. To address these issues, we created mice transgenic for a bacterial artificial chromosome (BAC) containing the gene for human Langerin into which Cre recombinase had been inserted by homologous recombination (Langerin-Cre). These mice express Cre selectively in LCs, and they were bred to floxed TGFβRII and TGFβ1 mice, thereby generating mice with LCs that either cannot respond to or generate TGFβ1, respectively. Langerin-Cre TGFβRII mice had substantially reduced numbers of epidermal LCs, demonstrating that TGFβ1 acts directly on LCs in vivo. Interestingly, Langerin-Cre TGFβ1 mice also had very few LCs both in the steady state and after BM transplantation. Thus, TGFβ1 derived from LCs acts directly on LCs through an autocrine/paracrine loop, and it is required for LC development and/or survival.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20071401

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endogenous TGF-β1 is essential for normal murine Langerhans cell development and TGF-β1 acts directly on Langerhans cells through an autocrine/paracrine loop.

    “it has been reported that endogenous TGF-β1 is essential for normal murine Langerhans cell development35 and TGF-β1 acts directly on Langerhans cells through an autocrine/paracrine loop36.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. [1]Romani, N., S. Holzmann, C.H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells - dendritic cells of the epidermis. APMIS. 111: 725–740. 12974775
  2. [2]Hemmi, H., M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J.J. Letterio, T. Nakabayashi, H. Tagaya, et al. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells. Int. Immunol. 13: 695–704. 11312257
  3. [3]Kripke, M.L., C.G. Munn, A. Jeevan, J.M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145: 2833–2838. 2212665
  4. [4]Larregina, A.T., A.E. Morelli, L.A. Spencer, A.J. Logar, S.C. Watkins, A.W. Thomson, and L.D. Falo Jr. 2001. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2: 1151–1158. 11702065
  5. [5]Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, M. Loubeau, X.M. Dai, E.R. Stanley, G.J. Randolph, and M. Merad. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7: 265–273. 16444257 PMC4727824
  6. [6]Strobl, H., E. Riedl, C. Scheinecker, C. Bello-Fernandez, W.F. Pickl, K. Rappersberger, O. Majdic, and W. Knapp. 1996. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157: 1499–1507. 8759731
  7. [7]Geissmann, F., C. Prost, J.P. Monnet, M. Dy, N. Brousse, and O. Hermine. 1998. Transforming growth factor β1, in the presence of granulocyte/macrophage colony–stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187: 961–966. 9500798 PMC2212193
  8. [8]Borkowski, T.A., J.J. Letterio, A.G. Farr, and M.C. Udey. 1996. A role for endogenous transforming growth factor β1 in Langerhans cell biology: the skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184: 2417–2422. 8976197 PMC2196398
  9. [9]Li, M.O., Y.Y. Wan, S. Sanjabi, A.K. Robertson, and R.A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24: 99–146. 16551245
  10. [10]Thomas, R.M., D.V. Belsito, C. Huang, L.Z. Chen Lz, I. Ormsby, W.J. Simmons, P. Cowin, J. Shaw, T. Doetschman, and G.J. Thorbecke. 2001. Appearance of Langerhans cells in the epidermis of Tgfb1(−/−) SCID mice: paracrine and autocrine effects of transforming growth factor-beta 1 and -beta 2(1). J. Invest. Dermatol. 117: 1574–1580. 11886525
  11. [11]Borkowski, T.A., J.J. Letterio, C.L. Mackall, A. Saitoh, X.J. Wang, D.R. Roop, R.E. Gress, and M.C. Udey. 1997. A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. J. Clin. Invest. 100: 575–581. 9239404 PMC508224
  12. [12]Kaplan, D.H., M.C. Jenison, S. Saeland, W.D. Shlomchik, and M.J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity. 23: 611–620. 16356859
  13. [13]Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12: 71–81. 10661407
  14. [14]Tripp, C.H., S. Chang-Rodriguez, P. Stoitzner, S. Holzmann, H. Stossel, P. Douillard, S. Saeland, F. Koch, A. Elbe-Burger, and N. Romani. 2004. Ontogeny of Langerin/CD207 expression in the epidermis of mice. J. Invest. Dermatol. 122: 670–672. 15086552
  15. [15]Shimshek, D.R., J. Kim, M.R. Hubner, D.J. Spergel, F. Buchholz, E. Casanova, A.F. Stewart, P.H. Seeburg, and R. Sprengel. 2002. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis. 32: 19–26. 11835670
  16. [16]Misulovin, Z., X.W. Yang, W. Yu, N. Heintz, and E. Meffre. 2001. A rapid method for targeted modification and screening of recombinant bacterial artificial chromosome. J. Immunol. Methods. 257: 99–105. 11687243
  17. [17]Mao, X., Y. Fujiwara, A. Chapdelaine, H. Yang, and S.H. Orkin. 2001. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood. 97: 324–326. 11133778
  18. [18]Douillard, P., P. Stoitzner, C.H. Tripp, V. Clair-Moninot, S. Ait-Yahia, A.D. McLellan, A. Eggert, N. Romani, and S. Saeland. 2005. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125: 983–994. 16297200
  19. [19]Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C.H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 22: 643–654. 15894281
  20. [20]Chytil, A., M.A. Magnuson, C.V. Wright, and H.L. Moses. 2002. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis. 32: 73–75. 11857781
  21. [21]Holzmann, S., C.H. Tripp, M. Schmuth, K. Janke, F. Koch, S. Saeland, P. Stoitzner, and N. Romani. 2004. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J. Invest. Dermatol. 122: 1165–1174. 15140219
  22. [22]Merad, M., M.G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I.L. Weissman, J.G. Cyster, and E.G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3: 1135–1141. 12415265 PMC4727838
  23. [23]Thompson, N.L., K.C. Flanders, J.M. Smith, L.R. Ellingsworth, A.B. Roberts, and M.B. Sporn. 1989. Expression of transforming growth factor- β1 in specific cells and tissues of adult and neonatal mice. J. Cell Biol. 108: 661–669. 2645303 PMC2115426
  24. [24]Li, M.O., Y.Y. Wan, and R.A. Flavell. 2007. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity. 26: 579–591. 17481928
  25. [25]Takahara, K., Y. Omatsu, Y. Yashima, Y. Maeda, S. Tanaka, T. Iyoda, B.E. Clausen, K. Matsubara, J. Letterio, R.M. Steinman, et al. 2002. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int. Immunol. 14: 433–444. 11978773
  26. [26]Hacker, C., R.D. Kirsch, X.S. Ju, T. Hieronymus, T.C. Gust, C. Kuhl, T. Jorgas, S.M. Kurz, S. Rose-John, Y. Yokota, and M. Zenke. 2003. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4: 380–386. 12598895
  27. [27]Larsson, J., U. Blank, H. Helgadottir, J.M. Bjornsson, M. Ehinger, M.J. Goumans, X. Fan, P. Leveen, and S. Karlsson. 2003. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood. 102: 3129–3135. 12842983
  28. [28]Stoitzner, P., H. Stossel, M. Wankell, S. Hofer, C. Heufler, S. Werner, and N. Romani. 2005. Langerhans cells are strongly reduced in the skin of transgenic mice overexpressing follistatin in the epidermis. Eur. J. Cell Biol. 84: 733–741. 16180311
  29. [29]Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M.G. Manz, S.A. Lira, I. Charo, D.N. Cook, I.L. Weissman, S. Strober, and E.G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510–517. 15098028 PMC4727841
  30. [30]Shlomchik, M.J., D. Zharhary, T. Saunders, S.A. Camper, and M.G. Weigert. 1993. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5: 1329–1341. 8268138

Cited by

Sorted by citations

Authors
Kaplan, D. H., Li, M. O., Jenison, M. C., Shlomchik, W. D., Flavell, R. A., & Shlomchik, M. J.
Affiliations
  • 1Department of Dermatology
  • 3Section of Immunobiology,
  • 2Department of Laboratory Medicine
Venue
The Journal of Experimental Medicine
Published
2007-10-15
Volume
204
Issue
11
Pages
2545-2552
ISSN
  • 1540-9538
  • 0022-1007
Cited by
239
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review